施昕妤;谢尚丹;项超丽;李宝青;陈朝生;薛向阳;章慧娣;

• 1:温州医科大学基础医学院分子病毒学与免疫学研究所微生物与免疫学教研室
• 2:浙江大学医学院免疫研究所
• 3:温州医科大学附属第二医院
• 4:温州医科大学附属第一医院

摘要(Abstract)：

人类巨细胞病毒（Human cytomegalovirus,HCMV）感染是系统性红斑狼疮（Systemic lupus erythematosus,SLE）的重要病因，并会加剧疾病进展。然而，SLE患者外周血单个核细胞（Peripheral blood mononuclear cell,PBMC）中HCMV基因的表达谱及其特异性抗体特征尚未完全阐明，并且HCMV蛋白特异性抗体水平与SLE患者临床特征的相关性尚未得到证实。通过Poly(A)建库的mRNA转录组测序（Poly(A)RNA-Seq）检测3例SLE患者和3例健康对照者（Healthy control,HC）的PBMC中的HCMV基因表达谱。然后在10例SLE患者和10例HC的链特异性建库的mRNA转录组测序（strand-specific RNA-seq）结果中验证检测到的HCMV基因。除此之外，通过免疫信息学分析筛选HCMV基因的B细胞表位。ELISA用于检测120例SLE患者和75例HC血清中的HCMV特异性抗体水平，并将其与患者的临床特征相关联。本研究在SLE患者和HC的PBMC中检测到8个HCMV基因。免疫信息学分析筛选出7个HCMV基因的优势B细胞表位。与HC相比，SLE患者血清中UL32和UL82特异性抗体显著降低。UL32特异性抗体可能与SLE患者血细胞功能异常有关。UL82特异性抗体可能参与SLE患者免疫系统功能异常和肾脏功能障碍。受试者工作特征曲线（Receiver operating characteristic,ROC）分析表明，其中UL32特异性抗体可以有效区分SLE患者和HC。

关键词(KeyWords)： 人巨细胞病毒;系统性红斑狼疮;外周血单个核细胞;B细胞表位

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金（项目号：82001705）,题目：人巨细胞病毒US31基因促进SLE患者巨噬细胞NFKB2活化的机制研究;; 浙江省医药卫生科技项目（项目号：2019KY453）,题目：HCMV US31促进系统性红斑狼疮M1型巨噬细胞极化及分子机制~~

作者(Authors): 施昕妤;谢尚丹;项超丽;李宝青;陈朝生;薛向阳;章慧娣;

DOI: 10.13242/j.cnki.bingduxuebao.004261

参考文献(References)：

• [1] Lipsky P E. Systemic lupus erythematosus:an autoimmune disease of B cell hyperactivity[J]. Nat Immunol, 2001, 2(9):764-766.
• [2] Durcan L, O'Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults[J]. Lancet, 2019, 393(10188):2332-2343.
• [3] Lisnevskaia L, G. Murphy, and D. Isenberg. Systemic lupus erythematosus[J]. Lancet, 2014.
• [4] Illescas-Montes R, Corona-Castro C C, MelguizoRodríguez L, Ruiz C, Costela-Ruiz V J. Infectious processes and systemic lupus erythematosus[J].Immunology, 2019.
• [5] Balada E, Ramentol M, Felip L, Ordi-Ros J, SelvaO'Callaghan A, Simeón-Aznar C P, Solans-LaquéR,Vilardell-Tarrés M. Prevalence of HHV-8 in systemic autoimmune diseases[J]. J Clin Virol, 2015, 62:84-88.
• [6] Van Damme E, Van Loock M. Functional annotation of human cytomegalovirus gene products:an update[J].Front Microbiol, 2014, 5:218.
• [7] Roche K L, Nukui M, Krishna B A, O'Connor C M,Murphy E A. Selective 4-thiouracil labeling of RNA transcripts within latently infected cells after infection with human cytomegalovirus expressing functional uracil phosphoribosyltransferase[J]. J Virol, 2018.
• [8] Li F, Yang Y, Zhu X, Huang L, Xu J. Macrophage polarization modulates development of systemic lupus erythematosus[J]. Cell Physiol Biochem, 2015, 37(4):1279-1288.
• [9] Plachter B, Sinzger C, Jahn G. Cell types involved in replication and distribution of human cytomegalovirus[J]. Adv Virus Res, 1996, 46:195-261.
• [10]Guo G. The cytomegalovirus protein US31 induces inflammation through mono-macrophages in systemic lupus erythematosus by promoting NF-κB2 activation[J]. Cell Death&Disease 2018.
• [11]Chen J, Zhang H,Chen P. Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods[J]. Clinical Rheumatology, 2015(34(4):p. 691-8).
• [12]Guo G, Chen J, Zhang H, Li B, Zhang L, Zhu X, Xue X, Chen C. Different expressions of latent HCMV genes in UL133–UL138 locus was associated with systemic lupus erythematosus[J]. Molecular Genetics,Microbiology and Virology, 2017, 32(2):116-124.
• [13]Segal B H, Sneller M C. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases[J]. Rheum Dis Clin North Am, 1997, 23(2):219-237.
• [14]Rider J R, Ollier W E, Lock R J, Brookes S T,Pamphilon D H. Human cytomegalovirus infection and systemic lupus erythematosus[J]. Clin Exp Rheumatol,1997, 15(4):405-409.
• [15]Hrycek A, Kusmierz D, Mazurek U, Wilczok T.Human cytomegalovirus in patients with systemic lupus erythematosus[J]. Autoimmunity, 2005, 38(7):487-491.
• [16]Hsieh A H, Jhou Y J, Liang C T, Chang M, Wang S L. Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice[J]. Arthritis Res Ther, 2011, 13(5):R162.
• [17]Hochberg M C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum,1997, 40(9):1725.
• [18]Bombardier C, Gladman D D, Urowitz M B, Caron D,Chang C H. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE[J]. Arthritis Rheum, 1992, 35(6):630-640.
• [19]Kolaskar A S, Tongaonkar P C. A semi-empirical method for prediction of antigenic determinants on protein antigens[J]. FEBS Lett, 1990, 276(1-2):172-174.
• [20]Langhoff E, Siegel R E. Pneumonitis in human cytomegalovirus infection[J]. Curr Infect Dis Rep,2006, 8(3):222-230.
• [21]Pender M P. CD8+T-Cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity:A unifying hypothesis[J]. Autoimmune Dis, 2012, 2012:189096.
• [22]Tarrant-Elorza M, Rossetto C C, Pari G S.Maintenance and replication of the human cytomegalovirus genome during latency[J]. Cell Host Microbe, 2014, 16(1):43-54.
• [23]Zhang Q, Lai M M, Lou Y Y, Guo B H, Wang H Y,Zheng X Q. Transcriptome altered by latent human cytomegalovirus infection on THP-1 cells using RNAseq[J]. Gene, 2016, 594(1):144-150.
• [24]Hayashi,L., Lee S, Ogasawara H, Sekigawa I, Iida N, Tomino Y, Hashimoto and S Hirose H.Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection[J]. Lupus, 1998.
• [25]Momtaz S, Molina B, Mlera L, Goodrum F, Wilson J M. Cell type-specific biogenesis of novel vesicles containing viral products in human cytomegalovirus infection[J/OL]. J Virol, 2021,95(11):e02358-20.DOI:10.1128/JVI.02358-20.
• [26]Baxter M K, Gibson W. Cytomegalovirus basic phosphoprotein(pUL32)binds to capsids in vitro through its amino one-third[J]. J Virol, 2001, 75(15):6865-6873.
• [27]Julian L, Olson M F. Rho-associated coiled-coil containing kinases(ROCK):structure, regulation, and functions[J/OL]. Small GTPases, 2014, 5:e29846.